Science & Enterprise subscription

Follow us on Twitter

  • Evidence collected from electronic neuro-stimulation devices shows for most people the wearable systems relieve mig… https://t.co/2RsxkVvoUA
    about 17 hours ago
  • New post on Science and Enterprise: Wearable Device Shown to Relieve Migraine Pain https://t.co/mKP8iAVKCm #Science #Business
    about 17 hours ago
  • Two biotechnology companies are adding to their current collaboration to develop delivery techniques for gene-editi… https://t.co/uG1FkdMzJv
    about 20 hours ago
  • New post on Science and Enterprise: Biotechs Partner on Gene-Editing Cystic Fibrosis Therapy https://t.co/3tixJDiac0 #Science #Business
    about 20 hours ago
  • First results from a clinical trial testing an experimental synthetic antibody, show patients receiving the therapy… https://t.co/Cgw8tTAAKY
    about 2 days ago

Please share Science & Enterprise

Precision Cancer Therapy Start-Up Gains $110M in Early Funds

Human T-cell

A company creating cancer therapies with individualized engineered T-cells is raising $110 million in its first venture funding round. . . . → Read More: Precision Cancer Therapy Start-Up Gains $110M in Early Funds

Small Antibody Shown to Block Covid-19 Infection

Alpaca

Researchers in Sweden found a small-scale antibody grown in an alpaca that in lab tests blocks the SARS-CoV-2 infection mechanism. . . . → Read More: Small Antibody Shown to Block Covid-19 Infection

Brain Signal Synchronization Device in Development

Brain activity graphic

An implantable mental health therapy system is being designed to synchronize signaling rhythms from various regions of the brain. . . . → Read More: Brain Signal Synchronization Device in Development

Vaccine Blocks Covid-19 Infections in Animal Tests

Syringe

An experimental vaccine shows in challenge tests with monkeys it protects against Covid-19 infections in nose, throat, and airways. . . . → Read More: Vaccine Blocks Covid-19 Infections in Animal Tests

Small Biz Grant Advances Neuro Protection Drugs

Neurons

An NIH award to a biotechnology company funds discovery of drugs that protect brain cells from degenerative disorders like Alzheimer’s disease. . . . → Read More: Small Biz Grant Advances Neuro Protection Drugs

Start-Up to Engineer T-Cells for Autoimmune Diseases

Human T-cell

GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases. . . . → Read More: Start-Up to Engineer T-Cells for Autoimmune Diseases

Two Covid-19 Vaccines Show Preclinical Immune Responses

SARS-Cov-2 viruses

Two candidate vaccines to prevent Covid-19 infections show they generate immune protections in lab monkeys, with one vaccine for 13 weeks. . . . → Read More: Two Covid-19 Vaccines Show Preclinical Immune Responses

Synthetic Protein Designed to Boost Covid-19 Vaccines

Jason McLellan and Daniel Wrapp

Researchers in Texas designed a synthetic version of a protein found on Covid-19 viruses that can make it easier to produce more vaccines. . . . → Read More: Synthetic Protein Designed to Boost Covid-19 Vaccines

High-Capacity Brain Signal Reader Demonstrated

Brain circuits illustration

A brain-computer interface device is shown to record the highest volume of brain signals from lab animals and sheep, according to its developers. . . . → Read More: High-Capacity Brain Signal Reader Demonstrated

Start-Up Developing Coronavirus Antibodies, Raises $50M

Feeding bat

A new company is underway creating engineered antibodies to neutralize a range of coronaviruses, not just those causing Covid-19 infections. . . . → Read More: Start-Up Developing Coronavirus Antibodies, Raises $50M